All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring—Why Take the Slow Lane-Reference-Cited by-同舟云学术

All Optimal Dosing Roads Lead to Therapeutic Drug Monitoring—Why Take the Slow Lane

Published:2022-12-01 Issue:12 Volume:8 Page:1733
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Beumer Jan H.¹²,Chu Edward³,Salamone Salvatore J.⁴

Affiliation:

1. Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

2. Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania

3. Montefiore Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York

4. Saladax Biomedical Inc, Bethlehem, Pennsylvania

Abstract

This Viewpoint discusses therapeutic drug monitoring as a necessary treatment paradigm and the need for regulatory agencies to provide the conditions to make it happen.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2797724/jamaoncology_beumer_2022_vp_220021_1670534702.62729.pdf

Reference7 articles.

1. The drug-dosing conundrum in oncology—when less is more.;Shah;N Engl J Med,2021

2. KRASG12C inhibition with sotorasib in advanced solid tumors.;Hong;N Engl J Med,2020

3. Intrinsic and extrinsic pharmacokinetic variability of small molecule targeted cancer therapy.;Reyner;Clin Transl Sci,2020

4. Precision dosing of targeted therapies is ready for prime time.;Groenland;Clin Cancer Res,2021

5. Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology recommendations for 5-fluorouracil therapy.;Beumer;Clin Pharmacol Ther,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Project Confirm: Accelerated Drug Approvals for CML—Response;Clinical Cancer Research;2024-01-05

2. Project Confirm: Accelerated Drug Approvals for CML—Letter;Clinical Cancer Research;2024-01-05

3. Metronomic chemotherapy in cancer treatment: new wine in an old bottle;Theranostics;2024

4. Personalized Minimal Effective Concentration Therapy;Clinical Therapeutics;2023-12

5. The earlier the better? Or better late than never? Dose optimization in oncology;JNCI: Journal of the National Cancer Institute;2023-03-15